UniProt/SwissProt ID: | GDIB_HUMAN |
Description: | GDP dissociation inhibitor 2 [Source:HGNC Symbol;Acc:4227] |
Location: | chr10 p15.1 |
Node attribute: | substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
Y442 | KKNDIyGED__ | PhosphoSitePlus | |
S61 | FKIPGsPPESM | GDI | PhosphoSitePlus; SysPTM |
Y5 | _MNEEyDVIVL | GDI | PhosphoSitePlus |
Y203 | LDQPCyETINR | HPRD; phosphoELM | |
Y111 | EGSFVyKGGKI | HPRD | |
Y111 | EGSFVyKGGKI | GDI | PhosphoSitePlus |
Y38 | MDRNPyYGGES | GDI | PhosphoSitePlus |
T205 | QPCYEtINRIK | GDI | PhosphoSitePlus |
S396 | DLGTEsQIFIS | GDI | PhosphoSitePlus |
Y203 | LDQPCyETINR | GDI | PhosphoSitePlus |
Y93 | VKMLLyTEVTR | GDI | PhosphoSitePlus |
Y245 | RLSAIyGGTYM | GDI | PhosphoSitePlus |
Y197 | YRTDDyLDQPC | HPRD | |
S61 | FKIPGsPPESM | HPRD; phosphoELM; SysPTM | |
T394 | PKDLGtESQIF | GDI | PhosphoSitePlus |
Y349 | AAQGKyIAIVS | GDI | PhosphoSitePlus |
Y117 | KGGKIyKVPST | GDI | PhosphoSitePlus |
Y333 | RKSDIyVCMIS | GDI | PhosphoSitePlus |
S382 | EQKFVsISDLL | GDI | PhosphoSitePlus |
S330 | QVNRKsDIYVC | GDI | PhosphoSitePlus |
T122 | YKVPStEAEAL | GDI | PhosphoSitePlus |
Y224 | YGKSPyLYPLY | GDI | PhosphoSitePlus |
T355 | IAIVStTVETK | GDI | PhosphoSitePlus |
Y53 | PLEDLyKRFKI | GDI | PhosphoSitePlus |
Y229 | YLYPLyGLGEL | GDI | PhosphoSitePlus |
S121 | IYKVPsTEAEA | GDI | PhosphoSitePlus |
Y226 | KSPYLyPLYGL | GDI | PhosphoSitePlus |
T94 | KMLLYtEVTRY | GDI | PhosphoSitePlus |
Dephosphorylation site |
GDIB_HUMAN do not have dephosphorylation site. |
Mutation site |
GDIB_HUMAN do not have mutation site. |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000369538 | Breast Cancer | Normal vs. Cancer | tissue | Up | 3.6 | 20005186 |
ENSP00000369538 | Breast Cancer | Normal vs. Cancer | tissue | Up | 4.9 | 20005186 |
ENSP00000369538 | Breast Cancer | Normal vs. Cancer | cell line | Up | 1.2 | 20052998 |
ENSP00000369538 | Breast Cancer | Normal vs. Cancer | cell line | Up | 1.7 | 20052998 |
ENSP00000369538 | Breast Cancer | Metastasis | cell line | Up | 1.4 | 20052998 |
ENSP00000369538 | Breast Cancer | Normal vs. Cancer | cell line | Up | 1.5 | 20052998 |
ENSP00000369538 | Breast Cancer | Normal vs. Cancer | cell line | Up | 1.2 | 20052998 |
ENSP00000369538 | Breast Cancer | Metastasis | cell line | Down | 0.78 | 20052998 |
ENSP00000369538 | Ovarian Cancer | Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) | cell line | Down | 0.35 | 20858016 |
ENSP00000369538 | Biliary Tract Cancer | Metastasis | cell line | Up | 3 | 19299076 |
Hyperphosphorylation site |
GDIB_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
FAK2_HUMAN | GDIB_HUMAN | kinase -> substrate | Robert H Newman (2013) |
M4K2_HUMAN | GDIB_HUMAN | kinase -> substrate | Robert H Newman (2013) |
Function Annotation |
KEGG Pathway |
GDIB_HUMAN is not in KEGG pathway. |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0007165 | signal transduction | TAS | biological_process |
GO:0007264 | small GTPase mediated signal transduction | IEA | biological_process |
GO:0009986 | cell surface | IDA | cellular_component |
GO:0005093 | Rab GDP-dissociation inhibitor activity | IEA | molecular_function |
GO:0005097 | Rab GTPase activator activity | IEA | molecular_function |
GO:0005794 | Golgi apparatus | IEA | cellular_component |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0032851 | positive regulation of Rab GTPase activity | IEA | biological_process |
GO:0015031 | protein transport | IEA | biological_process |
GO:0016020 | membrane | IEA | cellular_component |
GO:0005829 | cytosol | TAS | cellular_component |
GO:0005737 | cytoplasm | TAS | cellular_component |
GO:0007264 | small GTPase mediated signal transduction | TAS | biological_process |
GO:0051056 | regulation of small GTPase mediated signal transdu | TAS | biological_process |